Codeine-containing cough medicines in UK to get new labels
This article was originally published in SRA
The UK Medicines and Healthcare products Regulatory Agency has recommended changes to the labelling and packaging of all codeine-containing oral liquid cough medicines that are sold over-the-counter. The agency states these should not used for treating children under 18 years old and should be sold in child-resistant containers1.
You may also be interested in...
Drug companies in the EU explain how a new pilot scheme on national-level scientific advice service can benefit drug developers.
While the Dutch government negotiates an acceptable price for Leadiant Biosciences’ orphan drug CDCA, a university hospital has resumed supplying pharmacy compounded versions of the drug after addressing initial problems with the sourcing of raw materials.
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.